Ziopharm Oncology reported $84.99M in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Amgen AMGN:US $ 59294M 98M
AstraZeneca AZN:LN 96579M 3694M
Baxter International BAX:US $ 31831M 885M
Biogen BIIB:US $ 25081.4M 1467M
Bioline Rx BLRX:US $ 74.77M 6.62M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Corcept Therapeutics CORT:US $ 496.36M 28.24M
Curis CRIS:US $ 128.83M 11.9M
Eleven Biotherapeutics EBIO:US $ 225.84M 14.91M
Gilead Sciences GILD:US $ 62870M 210M
GlaxoSmithKline GSK:LN 89045M 644M
Immunogen IMGN:US $ 422.3M 59.41M
Intercept Pharmaceuticals ICPT:US $ 498.6M 4.76M
Intrexon XON:US $ 321.22M 14.34M
IONIS PHARMACEUT IONS:US $ 2456.13M 62.96M
Karyopharm Therapeutics KPTI:US $ 256.48M 37.56M
Novartis NOVN:VX SF 122910M 2308M
Ptc Therapeutics PTCT:US $ 1804.06M 4.47M
Regeneron Pharmaceuticals REGN:US $ 27205.8M 857.1M
Sangamo Biosciences SGMO:US $ 617.13M 37.18M
Tg Therapeutics TGTX:US $ 251.67M 51.36M
Verastem VSTM:US $ 100.41M 15.74M
YTE INCY:US $ 5319.04M 264.81M
Ziopharm Oncology ZIOP:US $ 84.99M 9.87M